Racura Oncology (ASX:RAC)

ASX announcement history & article coverage

25
Total announcements
(in last 3 months)
6
With article
19
No article
Article coverage
24%
Transparent by design. Announcments by Racura Oncology (ASX:RAC) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.

1 Sept 2026 · 01:15 pm AEST ASX Filing
Notification regarding unquoted securities - RAC
1 Sept 2026 · 08:58 am AEST ⚡ Price SensitiveMaterial ASX Filing
CPACS Trial Opens for RC220 Patient Enrolment in Korea
Racura Oncology Opens Korean Sites for CPACS Trial Patient Enrolment

25 Aug 2026 · 05:22 pm AEST ASX Filing
Corporate Governance Statement
25 Aug 2026 · 05:21 pm AEST ASX Filing
Appendix 4G
25 Aug 2026 · 05:21 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Appendix 4E & Annual Report
Racura Oncology reports $11.1M loss, advances MYC-targeting cancer drug with strong funding

29 July 2026 · 09:12 am AEST ASX Filing
Racure Oncology Techknow Invest Presentation
29 July 2026 · 09:04 am AEST ⚡ Price SensitiveMaterial ASX Filing
First HARNESS-1 Patient Safely Treated with RC220
Racura Oncology's HARNESS-1 trial progresses with SRC review and additional patient dosing after Grade 2 colitis reported
28 July 2026 · 09:12 am AEST ⚡ Price SensitiveMaterial ASX Filing
June 2026 Quarterly Activities Report and Appendix 4C
Racura Oncology advances clinical trials and secures $34.3M cash runway into 2028
13 July 2026 · 08:57 am AEST ASX Filing
Notification of cessation of securities - RAC
9 July 2026 · 10:42 am AEST ASX Filing
Racura to Present CPACS Data at GCOS 2026
6 July 2026 · 12:38 pm AEST ASX Filing
Racura Oncology New Zealand Investor Events
3 July 2026 · 08:46 am AEST ⚡ Price SensitiveMaterial ASX Filing
Bellberry Ethics Approval Activates New HARNESS Trial Sites
Bellberry Ethics Approval Enables Expansion of Racura's HARNESS-1 Lung Cancer Trial Sites
2 July 2026 · 08:29 am AEST ASX Filing
Notification of cessation of securities - RAC

25 June 2026 · 08:55 am AEST ⚡ Price SensitiveMaterial ASX Filing
Racura Treats First Patient in HARNESS-1 Lung Cancer Trial
Racura Oncology Treats First Patient in Phase 1 HARNESS-1 Lung Cancer Trial
16 June 2026 · 12:54 pm AEST ASX Filing
Racura Oncology Investor Briefings Perth & Auckland
16 June 2026 · 12:36 pm AEST ⚡ Price SensitiveMaterial ASX Filing
Racura raised $34.3m to Advance Three Oncology Trials
Racura Oncology Raises $34.3 Million to Fund Three Oncology Clinical Trials
16 June 2026 · 12:33 pm AEST ASX Filing
Cleansing Notice
16 June 2026 · 12:27 pm AEST ASX Filing
Application for quotation of securities - RAC
11 June 2026 · 02:50 pm AEST ASX Filing
Cleansing Notice
11 June 2026 · 02:49 pm AEST ASX Filing
Application for quotation of securities - RAC
9 June 2026 · 08:48 am AEST ASX Filing
Appendix 3Y-Dr Serge Scrofani
4 June 2026 · 12:02 pm AEST ASX Filing
Racura Options Raised $24.4m
4 June 2026 · 11:57 am AEST ASX Filing
Notification of cessation of securities - RAC
4 June 2026 · 08:52 am AEST ASX Filing
Proposed issue of securities - RAC
4 June 2026 · 08:50 am AEST ⚡ Price SensitiveMaterial ASX Filing
Emerging Companies Specialist Invests in Racura
Racura Oncology raises $31.2 million including $1 million private placement to specialist investor